Literature DB >> 5038956

Hematuria and crystalluria after high-dose 6-mercaptopurine administration.

M J Duttera, R L Carolla, J F Gallelli, D S Gullion, D E Keim, E S Henderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5038956     DOI： 10.1056/NEJM197208102870609

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomas.

Authors:  D C Smith; N A Vick; D L Trump; H S Friedman; A H Friedman; J Purvis; A Gauspari; S C Schold
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Phase II evaluation and plasma pharmacokinetics of high-dose intravenous 6-thioguanine in patients with colorectal carcinoma.

Authors:  P H Konits; M J Egorin; D A Van Echo; J Aisner; P A Andrews; M E May; N R Bachur; P H Wiernik
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  6-mercaptopurine: high-dose 24-h infusions in goats.

Authors:  T J Schouten; R A De Abreu; E D Schretlen; J M van Baal; M B van Leeuwen; G A de Vaan
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.